Vaccitech PLC VACC:NASDAQ

RT Quote | NASDAQ | USD
Last | 06/17/21 EDT
13.95quote price arrow down-0.06 (-0.43%)
Volume
18,664
52 week range
12.25 - 17.99

...

Loading . . .
  • Open14.15
  • Day High14.29
  • Day Low13.90
  • Prev Close13.95
  • 52 Week High17.99
  • 52 Week High Date05/17/21
  • 52 Week Low12.25
  • 52 Week Low Date05/05/21

Key Stats

  • Market Cap478.90M
  • Shares Out34.33M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-

KEY STATS

  • Open14.15
  • Day High14.29
  • Day Low13.90
  • Prev Close13.95
  • 52 Week High17.99
  • 52 Week High Date05/17/21
  • 52 Week Low12.25
  • 52 Week Low Date05/05/21
  • Market Cap478.90M
  • Shares Out34.33M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.52
  • P/E (TTM)-26.84
  • Fwd P/E (NTM)-4.24
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Vaccitech PLC

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Vaccitech plc, formerly Vaccitech Ltd, is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer. The Company uses its platform to develop product candidates that targets immune responses against pathogens and tumor cells. The Company has pipeline of both clinical and preclinical stage therapeutic and prophylactic programs. Its...
Address
The Schrdinger Building
Heatley Road, The Oxford Science Park
Oxford
OX4 4GE
United Kingdom